<DOC>
	<DOCNO>NCT02860585</DOCNO>
	<brief_summary>The objective study evaluate outcome patient affect different subtypes metastatic breast cancer follow treatment high-dose chemotherapy autologous haematopoietic progenitor cell transplantation .</brief_summary>
	<brief_title>Evaluation Survival Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year Metastatic breast Cancer Treatment highdose chemotherapy autologous haematopoietic progenitor cell transplantation 2003 2012 Lack followup data</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Metastatic breast cancer</keyword>
	<keyword>high-dose chemotherapy</keyword>
	<keyword>autologous haematopoietic progenitor cell transplantation</keyword>
</DOC>